These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8821047)
21. Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration. Li L; Sengupta A; Haque N; Grundke-Iqbal I; Iqbal K FEBS Lett; 2004 May; 566(1-3):261-9. PubMed ID: 15147906 [TBL] [Abstract][Full Text] [Related]
22. Post-training N-methyl-D-aspartate receptor blockade offers protection from retrograde interference but does not affect consolidation of weak or strong memory traces in the water maze. Day M; Langston RF Neuroscience; 2006; 137(1):19-28. PubMed ID: 16289349 [TBL] [Abstract][Full Text] [Related]
23. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Lipton SA Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine. Nicholson KL; Jones HE; Balster RL Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937 [TBL] [Abstract][Full Text] [Related]
25. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia. Wedzony K; Fijal K; Mackowiak M; Chocyk A; Zajaczkowski W Neuroscience; 2008 Jun; 153(4):1370-9. PubMed ID: 18434025 [TBL] [Abstract][Full Text] [Related]
26. Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain. Cauli O; Rodrigo R; Boix J; Piedrafita B; Agusti A; Felipo V Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G503-11. PubMed ID: 18599589 [TBL] [Abstract][Full Text] [Related]
27. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease. Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597 [TBL] [Abstract][Full Text] [Related]
28. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Danysz W; Parsons CG Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S23-32. PubMed ID: 12973747 [TBL] [Abstract][Full Text] [Related]
29. N-methyl-D-aspartate receptors in the medial septal area have a role in spatial and emotional learning in the rat. Elvander-Tottie E; Eriksson TM; Sandin J; Ogren SO Neuroscience; 2006 Nov; 142(4):963-78. PubMed ID: 16952425 [TBL] [Abstract][Full Text] [Related]
30. Memantine and recognition memory: possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine. Pitsikas N; Sakellaridis N Eur J Pharmacol; 2007 Oct; 571(2-3):174-9. PubMed ID: 17628527 [TBL] [Abstract][Full Text] [Related]
31. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5. Steele RJ; Morris RG Hippocampus; 1999; 9(2):118-36. PubMed ID: 10226773 [TBL] [Abstract][Full Text] [Related]
32. NMDA antagonists inhibit the development of ethanol dependence in rats. Kotlińska J Pol J Pharmacol; 2001; 53(1):47-50. PubMed ID: 11785910 [TBL] [Abstract][Full Text] [Related]
33. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Vorwerk CK; Lipton SA; Zurakowski D; Hyman BT; Sabel BA; Dreyer EB Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1618-24. PubMed ID: 8675405 [TBL] [Abstract][Full Text] [Related]
34. NMDA receptor blockers prevents the facilitatory effects of post-training intra-dorsal hippocampal NMDA and physostigmine on memory retention of passive avoidance learning in rats. Jafari-Sabet M Behav Brain Res; 2006 Apr; 169(1):120-7. PubMed ID: 16443290 [TBL] [Abstract][Full Text] [Related]
35. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. David HN; Ansseau M; Lemaire M; Abraini JH Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030 [TBL] [Abstract][Full Text] [Related]
39. Memantine exacerbates myoclonic jerks in a rat model of posthypoxic myoclonus. Tai KK; Truong DD Brain Res; 2010 Jul; 1343():194-8. PubMed ID: 20434435 [TBL] [Abstract][Full Text] [Related]
40. Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression? Réus GZ; Stringari RB; Kirsch TR; Fries GR; Kapczinski F; Roesler R; Quevedo J Brain Res Bull; 2010 Apr; 81(6):585-9. PubMed ID: 19954760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]